GiT Updates and More
Kanalga Telegramâda oâtish
Gi doctor with interests in endoscopy, gut health, liver & medicine in general.
Ko'proq ko'rsatish5 321
Obunachilar
+124 soatlar
+277 kun
+9530 kun
Postlar arxiv
5 321
Spotlight: Pharmacologic Management of Moderate-to-Severe Crohnâs Disease
5 321
Real-world evidence of the impact of aspirin use on esophageal cancer incidence in Barrettâs esophagus patients.
Taylor&francis Nobember 2025
5 321
HCC surveillance is essential in at-Ârisk CHB patients, even if virologically suppressed or after HBsAg loss. Continue surveillance in all with cirrhosis, family history or HBsAg loss >50 years. Risk scores (PAGE-ÂB, mPAGE-ÂB, REACH-ÂB, aMAP) can help personalise surveillance.
